Concepedia

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study

Claus Vogelmeier, Eric Bateman, John Pallante, Vijay Alagappan, Peter D’Andrea, Hungta Chen, Donald Banerji

The Lancet Respiratory Medicine · 2012 · 315 citations · 20 references

DOI

Concepts

References

20

Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

Peter Calverley, Julie A. Anderson, Bartolomé R. Celli et al. · New England Journal of Medicine · 2007 · 3.3K citations · Full text

, , +1

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

John R. Hurst, Jørgen Vestbo, Antonio Anzueto et al. · New England Journal of Medicine · 2010 · 3K citations · Full text

, , +14

Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease

N. R. Anthonisen · Annals of Internal Medicine · 1987 · 2.5K citations

, , +13

The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide

Jadwiga A. Wedzicha, Peter M.A. Calverley, Terence Seemungal et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 843 citations

, , +17

Use of Inhaled Corticosteroids and the Risk of Cataracts

Robert G. Cumming, Paul Mitchell, Stephen Leeder · New England Journal of Medicine · 1997 · 525 citations · Full text

, , +17